Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Interview released: IMS Health discussing New Cancer Drugs Fund (CDF) impact on market access

SMi Group
Posted on: 25 Aug 16
Interview released: IMS Health discussing New Cancer Drugs Fund (CDF) impact on market access

SMi’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference will be returning to London, UK on 10-11 October 2016.

SMi Group caught up with the conference speaker Smita Sealey UK Engagement Manager, Market Access, IMS Health to find out her thoughts about new cancer drug fund impact on market access and more.

In the interview Smita Sealey said: “…The new CDF is a very different beast from the one it replaces. The old scheme was £126 million overspent, despite several attempts by NHS England to de-list drugs not perceived as delivering value. Something clearly had to give, but whether the new arrangements succeed in bringing expensive cancer drugs to patients, while still balancing the books, remains to be seen…. At the event this October I will discuss is the new process working as well as expected. How has this new process increased market access? And what to expect next?...”

Smita Sealy will be presenting on: The Cancer Drugs Fund (CDF) UK 2016: What have we learned from the translation period? at day 1 of the event.

To view the full interview please visit:

This year’s packed programme includes unique presentations, case studies and panel discussions delivered by leading experts from Shire International, IGES, Baxalta, Evidera, IGES, Cell & Gene Therapy Catapult, Office of Health Economics, Lundbeck, Novartis, Quintiles, Alcon and many more.

The conference will feature two exclusive post-conference workshops:
A: HTA and reimbursement decisions for innovative medicines
 Workshop Leader: Patrick Mollon, Former Director Global Health Economics & Outcomes Research, Novartis; HEOR Director, PMHE2020
B: Managing the global to local challenge
 Workshop Leader: Janice Haigh, Practice Leader, Quintiles
Attendees are advised to register before 31st August to save £100.

For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or
For delegate enquiries contact Fateja Begum +44 (0) 20 7827 6184 or email
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email:


---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at

For more information:

Editor's Details

Anna Serazetdinova
SMi Group
+44 (0) 207 827 6180

Last updated on: 25/08/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.